THE LANCET INFECTIOUS DISEASES TUBERCULOSIS SERIES FOR WORLD TB DAY MARCH 2018. Guest Editor: Sir/Prof Alimuddin Zumla. This Series of two ‘state of the art’ reviews and one Comment on the high level United Nations General Assembly meeting in New York in September 2018. The two reviews cover: a) developmental pipeline and landscape of new and repurposed tuberculosis drugs, treatment regimens, and host-directed therapies for drug-sensitive and drug-resistant tuberculosis, and b), the Series reviews developments and key achievements in the search for new tuberculosis diagnostics and biomarkers.
THE LANCET RESPIRATORY MEDICINE TUBERCULOSIS SERIES: Lead coordinator of 3 articles: one review and 2 Comments: http://www.thelancet.com/action/doSearch?searchType=quick&searchText=TUBERCULOSIS&occurrences=all&journalCode=lanres&searchScope=series&seriesISSNFltraddfilter=2213-2600&journalCode=lanres
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, (2017) March 24th, World TB Day issue. Chief Editor Prof Zumla and Eskild Petersen, with co-editors: Markus Maeurer, Ben Marais, GB
Migliori. Huge volume of 44 articles written by over 200 global authors. Launched at World TB Day event at Royal Society of Medicine, London and UCL IGH, UK (March 24th, 2017).
1999-2016: CURRENT OPINIONS IN PULMONARY MEDICINE Annual INFECTIOUS DISEASES VOLUME SERIES
Annual Volumes: (1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2007, 2008, 2009, 2010, 2011,2012, 2013, 2014, 2015, 2016) Annual volumes from 1999 to date focussed on Respiratory tract Infection. 14 volumes edited so far – May issue annually (each has 14-17 review articles written by several global experts):
CLINICAL INFECTIOUS DISEASES- ADVANCES IN TB RESEARCH: A BLUEPRINT FOR OPPORTUNITIES - 2015. Advances in TB Research: A blueprint for opportunities. Guest Editors: Dr Marco Schito (NIH/CPTR); Markus Maeurer and Alimuddin Zumla. A 16 article volume. This supplement provides an update on the status of Mycobacterium tuberculosis (Mtb) research for drugs, vaccines, and diagnostics, and the intersection of these disciplines to better understand tuberculosis disease pathogenesis. Interest remains high in using cellular therapy and harnessing regulatory networks to either suppress Mtb growth or alleviate pathology due to host–pathogen interactions. In addition, epidemiological disease modeling, diagnostic impact assessment, the search for novel biomarkers, and regulatory challenges are highlighted separately. Advances in pediatrics include updates to the National Institutes of Health case definitions and a roadmap to meet the diagnostic needs.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES TUBERCULOSIS VOLUME - 2015
March 24th, World TB Day issue (Chief Editor with co-editors Eskild Petersen, Markus Maeurer, Jeremiah Chakaya, Christian Wejse, Ben Marais, Marc Lipman, Tim McHugh. The issue contained 33 articles written by over 200 global authors and is featured as part of a multi-journal virtual special issue published by Elsevier to commemorate World TB Day 2015.
THE LANCET SERIES ON MASS GATHERINGS MEDICINE - 2014
These state of the art reports, led by Professor Ziad Memish, Deputy Minister of Health for Public Health in Saudi Arabia, and Professor Alimuddin Zumla, at University College London Medical School, UK, set out the planning and surveillance systems used to monitor public health risks, and describe the public health experiences and lessons learnt for the planning of future events. Contains series of papers on mass gatherings and public health: i). The London 2012 Olympic and Paralympic Games; ii). The 2012 European Football Championship finals (Euro 2012), hosted jointly by Poland and Ukraine; and iii). The Hajj 2012/2013. Launched at the World Health Assembly of Ministers of Health, Geneva, May 26th 2014.
THE LANCET INFECTIOUS DISEASES AND THE LANCET RESPIRATORY MEDICINE. 2014. Lancet TB Series World TB Day 2014
This volume contains five Comments and three Reviews, and discusses topics ranging from host-directed therapies and vaccines, extremely drug-resistant tuberculosis, and new anti-tuberculosis drugs, highlighting not only past successes, but also the challenges that need to be met to win the battle against tuberculosis. Launched at the UCL/LSHTM global symposium on TB at the LSHTM March 24th,2014.
THE LANCET INFECTIOUS DISEASES THEME SERIES on emerging respiratory tract infections (2014).
Contains five state-of-the-art papers on the topics of surveillance, pandemic potential, transmission and the environment, diagnosis, and treatment. The focus is on the emerging viral pathogens (particularly influenza, coronaviruses, MDR-TB and antimicrobial resistant fungi and bacteria) that pose the greatest current global threat. Launched at ICAAC, Washington, September 3rd,2014.
THE LANCET INFECTIOUS DISEASES TB THEME SERIES to commemorate World TB Day (2013).
Commissioned by the Lancet Infectious Diseases Editor Dr John McConnell to Prof Zumla and Dr Marco Schito of NIH, Washington DC to lead this series of 6 state of the art review, and 3 viewpoint articles. All articles were peer reviewed this series will be published in LID and will be launched at World TB Day event to be held at UCL on Monday March 25th 2013. Several international speakers, guests and members of the APPG-GTB and APPG-Global Health attended.
THE JOURNAL OF INFECTIOUS DISEASES to commemorate World TB Day (2012).
In order to get USA TB/HIV fraternity more involved in global collaborations on TB and to generate lateral ‘out of the box’ thinking for TB and TB/HIV co-infection, Professor Zumla approached Profs Marco Schito and Richard Hafner of the NIH and asked them to join in a global effort in developing visibility through the journal JID. This was a resounding success with 23 articles written by 164 global experts. The volume: Tuberculosis and TB/HIV: Controversies and unanswered questions', is a Journal of Infectious Diseases special supplement edited by Professor Ali Zumla and Marco Schito (National Institutes of Health, USA).This was launched at UCL on World TB Day conference organised by Prof Zumla on March 23rd 2012 where 17 international speakers came at their own costs to present their work. Professor Zumla invited Baroness Susan Masham, Vice chair of the UK All Party Parliamentary group on Global TB (Prof Zumla is chair of the International Scientific Advisory Expert Group to the APPG-GTB) to attend and she, and other members of the APPG-GTB kindly graced the occasion: See website for details and presentations:
THE LANCET TB THEME SERIES to commemorate World TB Day (2010).
In 2008, the Editors of the Lancet TB Richard Horton and Pamela Das, in search of a lead internationally acclaimed ‘guru’ to lead a TB Series Theme Series of 7 articles and 7 commentaries, upon advice from external advisers, selected and requested Professor Ali Zumla to lead the LANCET series in a multi-author theme volume of 8 major state of the art review articles and 6 commentaries Professor Zumla and took on Professors Mario Raviglione, Director of WHO STOP TB Partnership in Geneva, and Professor Ben Marais (TB paediatrician from South Africa) as co-gurus and they developed, led and coordinated the entire series over 2 years. The Lancet TB Theme Series (2010) was launched at the World Health Assembly of Ministers of Health from 194 countries in Geneva on May 17th 2010. This series has provided excellent advocacy for TB and generated large investments of TB funding for R&D priorities and operational research.
THE LANCET TB THEME SERIES to commemorate World TB Day (2006).